Immunotherapeutics against cancer and infectious diseases

ISA Pharmaceuticals B.V. is an immunotherapy company developing rationally designed, fully synthetic therapeutic vaccines against cancer and persistent viral infections.

News

July 7, 2014
ISA Pharmaceuticals Appoints Ronald Loggers as Chief Executive Officer
April 10, 2014
New Clinical Data Demonstrate Strong Synergy between Cancer Vaccine ISA101 and Chemotherapy

Events

August 21 – 25, 2014
HPV 2014
November 3 – 5, 2014
BIO-Europe 2014

Latest Publications

September 22, 2013
ECCO-ESMO
Prior chemotherapy improves the immune response to a synthetic long peptide cancer vaccine against HPV16: a phase I toxicity-immunogenicity study in cervical cancer patients

More news

More events

More publications

Loading Quotes...